
Opinion|Videos|March 20, 2025
Managing ADC Toxicities and Infusion Reactions With Supportive Care Strategies
Panelists discuss how antibody-drug conjugates (ADCs) often cause toxic adverse events (AEs). Supportive care includes antiemetics, corticosteroids, and growth factors. Infusion reactions are managed with premedication and slow titration.
Advertisement
Episodes in this series

Video content above has been prompted by the following:
- Current ADCs in this space have fairly toxic AE profiles. What supportive care agents do you utilize when treating a patient with ADC therapy?
- In your practice, how do you address the potential for infusion-related reactions, and how do you manage their occurrence?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
3
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
4
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
5


















































































































































































































